1. Home
  2. ALLK vs IROQ Comparison

ALLK vs IROQ Comparison

Compare ALLK & IROQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALLK
  • IROQ
  • Stock Information
  • Founded
  • ALLK 2012
  • IROQ 1883
  • Country
  • ALLK United States
  • IROQ United States
  • Employees
  • ALLK N/A
  • IROQ N/A
  • Industry
  • ALLK Biotechnology: Pharmaceutical Preparations
  • IROQ Savings Institutions
  • Sector
  • ALLK Health Care
  • IROQ Finance
  • Exchange
  • ALLK Nasdaq
  • IROQ Nasdaq
  • Market Cap
  • ALLK 58.0M
  • IROQ 60.4M
  • IPO Year
  • ALLK 2018
  • IROQ 2011
  • Fundamental
  • Price
  • ALLK $1.16
  • IROQ $19.85
  • Analyst Decision
  • ALLK Hold
  • IROQ
  • Analyst Count
  • ALLK 5
  • IROQ 0
  • Target Price
  • ALLK $1.67
  • IROQ N/A
  • AVG Volume (30 Days)
  • ALLK 1.3M
  • IROQ 3.0K
  • Earning Date
  • ALLK 11-06-2024
  • IROQ 11-04-2024
  • Dividend Yield
  • ALLK N/A
  • IROQ 2.02%
  • EPS Growth
  • ALLK N/A
  • IROQ N/A
  • EPS
  • ALLK N/A
  • IROQ 0.62
  • Revenue
  • ALLK N/A
  • IROQ $22,441,000.00
  • Revenue This Year
  • ALLK N/A
  • IROQ N/A
  • Revenue Next Year
  • ALLK N/A
  • IROQ N/A
  • P/E Ratio
  • ALLK N/A
  • IROQ $31.81
  • Revenue Growth
  • ALLK N/A
  • IROQ N/A
  • 52 Week Low
  • ALLK $0.54
  • IROQ $14.00
  • 52 Week High
  • ALLK $3.41
  • IROQ $22.00
  • Technical
  • Relative Strength Index (RSI)
  • ALLK 51.18
  • IROQ 38.05
  • Support Level
  • ALLK $1.29
  • IROQ $20.71
  • Resistance Level
  • ALLK $1.56
  • IROQ $22.00
  • Average True Range (ATR)
  • ALLK 0.14
  • IROQ 0.23
  • MACD
  • ALLK -0.03
  • IROQ -0.15
  • Stochastic Oscillator
  • ALLK 14.89
  • IROQ 0.00

About ALLK Allakos Inc.

Allakos Inc is a clinical-stage company developing therapeutic antibodies that selectively target immunomodulatory receptors present on the surface of immune effector cells involved in allergic, inflammatory, and proliferative diseases. The company's lead program, AK006 targets Siglec-6, an inhibitory receptor expressed selectively on mast cells. Binding of AK006 to Siglec-6 is designed to activate the native inhibitory function of the receptor which in turn reduces mast cell activation.

About IROQ IF Bancorp Inc.

IF Bancorp Inc is a holding company. It is mainly engaged in the business of directing, planning, and coordinating the business activities of Iroquois Federal. The company with the association take deposits from the general public and invest those deposits together with funds generated from operations and borrowings in various loans such as multi-family residential and mortgage loans, commercial real estate loans, home equity lines of credit, consumer loans, others, and also a variety of deposit accounts and alternative delivery channels.

Share on Social Networks: